| Financial Year |
March 31 2023 |
| Monetary Funds |
111,869,474.80 |
| Held-for-trading Financial Assets |
158,000.00 |
| Notes Receivable |
4,140,378.00 |
| Accounts Receivable |
68,872,249.01 |
| Advances to Suppliers |
132,959,343.45 |
| Other Receivables |
13,080,468.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
800,541,654.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,916,878.40 |
| Total Current Assets |
1,161,488,446.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,994,273.29 |
| Investment Properties |
-- |
| Fixed Assetes |
512,902,805.03 |
| Under-construction Projects |
1,618,911.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
970,277.15 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
146,948,811.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
110,790.96 |
| Deferred Income Tax Assets |
790,214.09 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
691,273,674.45 |
| Total Assets |
1,852,762,121.27 |
| Short-Term Loans |
820,565,961.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
57,923,263.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,196,675.39 |
| Taxes Payable |
6,435,081.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
51,687,655.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
8,931,364.47 |
| Sub-Total of Current Liabilities |
1,058,767,807.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
901,652.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,606,504.90 |
| Total Liabilities |
1,125,374,312.65 |
| Paid-In Capital(Or Share Stock) |
641,783,218.00 |
| Capital Surplus |
469,360,956.95 |
| Surplus Reserve |
16,315,761.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-452,856,071.23 |
| Minority Stockholder's Interest |
52,785,727.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
674,602,081.40 |
| Owner's Equity（Stockholder's Equity） |
727,387,808.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,852,762,121.27 |
